Target intelligence / Profile preview

Dental organic matrix

Molecular classification
Other
01

Overview

The dental organic matrix is a complex assembly of proteins, proteoglycans, and lipids that orchestrates the biomineralization and structural integrity of enamel and dentin (George & Veis, 2008). In enamel, the matrix is transient and primarily composed of amelogenins (90%), enamelins, and ameloblastins, which facilitate the organized growth of hydroxyapatite crystals before being largely removed during maturation (Gil-Bona & Bidlack, 2020). Recent studies have also identified the presence of keratins, such as KRT75, which contribute to enamel's mechanical properties and resistance to caries (Duverger et al., 2014). Dentin's organic matrix is permanent and consists of approximately 90% Type I collagen, providing a scaffold for mineral deposition regulated by non-collagenous proteins like dentin sialophosphoprotein (DSPP) and dentin matrix protein 1 (DMP1) (George & Veis, 2008). Pathological degradation of these molecules by host-derived matrix metalloproteinases (MMPs) is a key factor in dental caries and the failure of adhesive restorations (Tjäderhane et al., 2013). Therapeutic strategies include the use of enamel matrix derivatives for periodontal regeneration and MMP inhibitors like chlorhexidine to preserve the dentin-adhesive interface (Miron et al., 2016; Tjäderhane et al., 2013).

Other names
Organic molecules in tooth enamel and dentinTooth organic matrixEnamel organic matrixDentin organic matrixDental extracellular matrixTooth proteins
02

Mechanism of action

Therapeutic agents interact with the dental organic matrix through several mechanisms: matrix metalloproteinase (MMP) inhibition to prevent the degradation of collagen fibrils (e.g., chlorhexidine, doxycycline), biomimetic mineralization where protein analogs or peptides nucleate hydroxyapatite crystals (e.g., enamel matrix derivative, P11-4), and chemical cross-linking to stabilize the collagen scaffold and improve the durability of dental bonds (e.g., glutaraldehyde, carbodiimide) (Tjäderhane et al., 2013; Miron et al., 2016).

03

Biological functions

Signal transductionCell proliferationOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Immunogenicity of xenogenic matrix derivativesHypersensitivity to dental materialsDegradation of the resin-dentin hybrid layerPotential cytotoxicity of chemical cross-linkers
06

Interacting drugs

Enamel matrix derivative

7 more in the full profile.

07

Biomarkers

Dentin sialophosphoproteinAmelogeninDentin matrix protein 1Type I collagenC-terminal telopeptide of type I collagen

Beyond the preview

Go deeper on Dental organic matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dental organic matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call